
The Exciting Future of Targeted Therapies
Pfizer
Client | Pfizer
Locations | Snoqualmie, Washington / San Francisco, California
Category | Branded Content, Documentary
Services | Production, Post-Production
This short documentary explores the human side of a breakthrough in oncology: antibody drug conjugates (ADCs) — a form of precision cancer treatment designed to target tumors more accurately and reduce the harsh side effects of traditional chemotherapy.
At the heart of the story are Dr. Scott Peterson, a cancer researcher at the forefront of early drug discovery, and Dr. Hope Rugo, a breast cancer specialist whose personal experience as a caregiver fuels her commitment to compassionate care. Together, they reflect a shared mission: to deliver more effective, empathetic, and patient-centered cancer care.
More than a film about innovation in medicine, this is a story about persistence, empathy, and what happens when science is guided by humanity.
As part of Goodfellow’s work in documentary film production for healthcare and mission-driven organizations, this film captures what we value most: stories that bring humanity to the forefront. By exploring the personal motivations behind scientific discovery — and showing how innovations like antibody drug conjugates impact real lives — it reflects our belief that the most powerful storytelling connects science with emotion and innovation with empathy. That intersection defines our approach to cinematic, human-centered storytelling — helping brands and organizations communicate not just what they do, but why it matters.
Produced by Goodfellow
In partnership with Pfizer & BBC StoryWorks
Part of the Rewriting Cancer series presented by the Union for International Cancer Control (UICC)
“On those rare occasions where you get to work on something that makes it into a clinical study and then you see that it’s helping people — it’s amazing. It’s truly amazing.”